Aastrom Biosciences Inc (ASTM.O)

ASTM.O on Consolidated Issue listed on NASDAQ Capital Market

0.41USD
1 Jul 2013
Price Change (% chg)

$0.01 (+2.22%)
Prev Close
$0.40
Open
$0.41
Day's High
$0.43
Day's Low
$0.41
Volume
381,412
Avg. Vol
238,588
52-wk High
$2.19
52-wk Low
$0.40

ASTM.O

Chart for ASTM.O

About

Aastrom Biosciences, Inc. (Aastrom) is a development stage company. The Company is focused on the development of cell therapies to repair or regenerate damaged or diseased tissues. The Company is engaged in developing patient-specific, expanded multicellular therapies for uses in the treatment of severe, chronic ischemic... (more)

Overall

Beta: 0.05
Market Cap (Mil.): $18.73
Shares Outstanding (Mil.): 45.66
Dividend: --
Yield (%): --

Financials

  ASTM.O Industry Sector
P/E (TTM): -- 34.05 33.02
EPS (TTM): -0.72 -- --
ROI: -225.99 -2.50 19.07
ROE: -- -3.10 20.00
Search Stocks

Latest News about ASTM.O

Aastrom Biosciences ends drug trial, to cut half its workforce

- Aastrom Biosciences Inc said it would end the late-stage trial of its drug to treat critical limb ischemia (CLI), a form of peripheral arterial disease, and cut about half of its workforce, driving its shares to an all-time low.

27 Mar 2013

Aastrom Biosciences ends drug trial, to cut half its workforce

March 27 - Aastrom Biosciences Inc said it would end the late-stage trial of its drug to treat critical limb ischemia - a form of peripheral arterial disease - and cut about half of its workforce.

27 Mar 2013
» More ASTM.O News

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $86.63 +0.77
Medtronic, Inc. (MDT.N) $52.05 +0.58
Baxter International Inc. (BAX.N) $70.06 +0.79
Advanced Cell Technology, Inc. (ACTC.OB) $0.08 -0.00
Bioheart, Inc. (BHRT.PK) $0.02 +0.00
Athersys, Inc. (ATHX.OQ) $1.65 -0.01
Cytori Therapeutics Inc. (USA) (CYTX.OQ) $2.35 +0.05
Geron Corporation (GERN.OQ) $1.47 -0.03
Mesoblast limited (MSB.AX) $5.71 +0.39
Osiris Therapeutics, Inc. (OSIR.OQ) $10.11 +0.04

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - AASTROM BIOSCIENCES, INC. (ASTM-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
AASTROM BIOSCIENCES INC (ASTM) - REPORT FOR ACTIVE TRADERS
Provider: Pechala's Reports
$25.00
Buy
Aastrom Biosciences
Provider: S&P Capital IQ Quantitative Report
$58.00
Buy
AASTROM BIOSCIENCES INC (ASTM) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Aastrom Biosciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks